Tower Research Capital LLC (TRC) - TIMBER PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TIMBER PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,346
-24.8%
1,797
-38.5%
0.00%
Q2 2023$7,105
+78844.4%
2,924
-46.6%
0.00%
Q1 2023$95,4740.00%
Other shareholders
TIMBER PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 96,790$3910.12%
Yakira Capital Management, Inc. 26,366$78,4390.02%
TUDOR INVESTMENT CORP ET AL 251,037$746,8350.01%
VANGUARD GROUP INC 38,687$115,0940.00%
UBS Group AG 1,659$4,9360.00%
WELLS FARGO & COMPANY/MN 22$650.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 22,292$66,3440.00%
STATE STREET CORP 14,442$42,9650.00%
Citadel Advisors 16,260$48,3740.00%
View complete list of TIMBER PHARMACEUTICALS INC shareholders